Page last updated: 2024-11-10

selachyl alcohol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

selachyl alcohol: RN given refers to (Z-(+-))-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5282282
CHEBI ID34116
SCHEMBL ID81179
MeSH IDM0053741

Synonyms (38)

Synonym
(z)-(+-)-3-(9-octadecenyloxy)-1,2-propanediol
1,2-propanediol, 3-(9-octadecenyloxy)-, (z)-(+-)-
nsc 29230
34783-94-3
nsc-36089
selachyl alcohol
nsc-29230
1-o-octadec-9-enyl glycerol
(9z)-1-o-octadec-9-enyl glycerol
CHEBI:34116
3-[(9z)-octadec-9-en-1-yloxy]propane-1,2-diol
1-o-(9z-octadecenyl)-glycerol
3-[(z)-octadec-9-enoxy]propane-1,2-diol
593-31-7
einecs 209-787-7
unii-9734969ccz
octadec-9-enylglycerol
(z)-3-(9-octadecenyloxy)propane-1,2-diol
9734969ccz ,
.alpha.-monooleyl glyceryl ether
1,2-propanediol, 3-((9z)-9-octadecen-1-yloxy)-
.alpha.-glycerol monooleyl ether
oleyl glyceryl ether [inci]
1,2-propanediol, 3-(9-octadecenyloxy)-, (z)-
nikkol selachyl alcohol
oleyl glyceryl ether
1-glyceryl monooleyl ether
oleyl 1-glyceryl ether
(+/-)-oleyl 1-glyceryl ether
SCHEMBL81179
1-monooleyl-rac-glycerol
glycerol 1-oleyl ether
NRWMBHYHFFGEEC-KTKRTIGZSA-N
Q27115822
1,2-propanediol, 3-[(9z)-9-octadecenyloxy]-
DTXSID701021791
CS-0644027
HY-152899

Research Excerpts

Overview

Selachyl alcohol (SA) is a mono-oleyl glyceryl ether.

ExcerptReferenceRelevance
"Selachyl alcohol (SA) is a mono-oleyl glyceryl ether. "( Selachyl alcohol as an oral antihypertensive agent: a preliminary note.
Brooks, B; Brown, P; Byers, LW; Dowell, R; Muirhead, EE; Pitcock, JA, 1987
)
3.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkylglycerolA glycerol ether having at least one alkyl substituent on oxygen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (42.86)18.7374
1990's0 (0.00)18.2507
2000's3 (21.43)29.6817
2010's4 (28.57)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.26 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]